Venlafaxine 37.5 mg Immediate Release Tablets — Generic For Effexor — TEVA

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Venlafaxine tablets are an antidepressant medicine used to treat major depressive disorder in adults. The label says its effectiveness was shown in short-term controlled trials and in a longer-term trial for helping prevent relapse in patients who responded to treatment.

The label warns that antidepressants can increase the risk of suicidal thoughts or behavior in children, adolescents, and young adults, and that people of all ages should be watched closely for worsening depression, unusual behavior changes, or suicidality, especially when starting treatment or changing the dose. Venlafaxine tablets are not approved for pediatric use.

Venlafaxine should not be used with certain medicines called MAOIs, and it can cause serotonin syndrome, a potentially life-threatening reaction, especially when combined with other serotonergic drugs. The label also warns about sustained increases in blood pressure, possible angle-closure glaucoma in people with narrow angles, sexual dysfunction, and symptoms that may happen if the medicine is stopped suddenly.

Storage Information

protection, if needed, may be indicated if performed soon after ingestion or in symptomatic patients. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] in a dry place. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). store venlafaxine tablets? Store venlafaxine tablets at room temperature between 68°F and 77°F (20°C to 25°C).

Key Counseling Points

• Take venlafaxine exactly as prescribed on the label.
• Do not start or stop venlafaxine without checking with the prescriber, because stopping suddenly can cause withdrawal-like symptoms.
• Tell the prescriber right away about worsening depression, suicidal thoughts, unusual behavior changes, agitation, irritability, or insomnia.
• Do not use venlafaxine with MAO inhibitors, and report all medicines and supplements you take, including serotonergic drugs and St. Johnu2019s Wort.
• Watch for signs of serotonin syndrome such as agitation, hallucinations, fast heartbeat, blood pressure changes, sweating, shaking, stiffness, nausea, vomiting, or diarrhea.
• Blood pressure should be monitored during treatment because venlafaxine can cause sustained increases in blood pressure.
• Report eye pain or vision changes promptly, since antidepressants like venlafaxine may trigger angle-closure glaucoma in people with narrow angles.
• Tell the prescriber about any sexual side effects, because sexual dysfunction can occur with SNRIs like venlafaxine.
• If a dose is being reduced or the medicine is being stopped, the label recommends gradual tapering when possible.
• Keep follow-up appointments so the prescriber can review how well the medicine is working and watch for side effects.

Helpful Patient Education

Venlafaxine hydrochloride tablets are a prescription antidepressant used for the treatment of major depressive disorder. This DailyMed label includes important safety information on suicidal thoughts and behavior, serotonin syndrome, blood pressure increases, discontinuation symptoms, and other warnings that patients and caregivers should know.

This educational product information is based on the official label and is intended to help explain common counseling topics, precautions, and approved uses for venlafaxine tablets in plain language.

Medication Summary last generated: 2026-07-09 03:12:02